For Cldn1, the treatment with TGS 121 non-significantly decreased the gene expression compared with samples from animals with colitis; in contrast, the expression of Cldn5 increased; in the case of all other genes there were no differences in expression at the mRNA level between groups. This evidence concerns the gene CLDN1 and colitis.